Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • The dark side of the 'love hormone:' Similarities with the effects of alcohol

  • Cognitive process speed in teen years affects depression risk in adulthood

  • Stress levels linked to risk of liver disease death, study shows

  • Lower depression, better mental health during the Great Recession, national study finds

  • No link found between PTSD and cancer risk

  • Stress relief techniques help cancer patients overcome fear of treatment

  • Pets on Prozac: Drug treatment can help anxious dogs

  • Depression intensifies anger in veterans with PTSD

  • It doesn't take a brain injury to have headache, dizziness and cognitive impairment

  • How managers and colleagues can help staff who witness workplace aggression

  •